V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017385 | 220014353 | 1.81 | null | null | 2014-11-26 | 2014-11-27 | Rituximab | N | N | 220030395 | RITUXIMAB |
| 220017387 | 220007942 | 1.57 | 78.6 | null | 2014-02-18 | 2014-02-18 | Dasatinib | N | Y | 220030429 | DASATINIB |
| 220017388 | 220007943 | 0 | 68.9 | null | 2016-09-24 | 2016-09-24 | Dasatinib | 2 | N | 220030431 | DASATINIB |
| 220017389 | 220017833 | 1.49 | 69.4 | Palliative (P) | null | 2017-09-15 | AML 18 TRIAL | 01 | N | 220030435 | AML18 TRIAL |
| 220017390 | 220007951 | 1.74 | null | Curative (C) | 2013-08-24 | 2014-01-10 | Dasatinib | N | N | 220030438 | DASATINIB |
| 220017391 | 220007954 | null | 69 | Curative (C) | 2015-10-21 | 2015-10-21 | Dasatinib | 99 | N | 220030445 | DASATINIB |
| 220017392 | 220007954 | null | 67.3 | Curative (C) | 2016-09-17 | 2016-09-21 | AML 18 TRIAL | N | null | 220030445 | AML18 TRIAL |
| 220017393 | 220007956 | 1.88 | null | Palliative (P) | 2017-04-26 | 2017-04-29 | Dasatinib | N | null | 220030458 | DASATINIB |
| 220017394 | 220007957 | null | null | null | 2016-07-31 | 2016-08-05 | Dasatinib | 02 | N | 220030460 | DASATINIB |
| 220017395 | 220007958 | 0 | 83 | Disease modification (D) | 2015-09-17 | 2015-10-01 | Rituximab | N | null | 220030463 | RITUXIMAB |
| 220017396 | 220007959 | 1.7 | 72 | Curative (C) | 2013-10-05 | 2013-10-05 | AML18 PILOT TRIAL | Y | N | 220030466 | PILOT TRIAL |
| 220017397 | 220007959 | 1.76 | 0 | Curative (C) | 2015-01-02 | 2015-02-12 | Dasatinib | N | N | 220030466 | DASATINIB |
| 220017398 | 220007963 | 1.79 | 56.5 | Curative (C) | 2018-02-01 | 2018-02-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030475 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017399 | 220007968 | 1.66 | null | null | 2017-06-20 | 2017-06-27 | Dasatinib | N | N | 220030478 | DASATINIB |
| 220017401 | 220007976 | 0 | 81.6 | Curative (C) | 2018-04-23 | 2018-04-23 | AML18 PILOT TRIAL | null | N | 220030494 | PILOT TRIAL |
| 220017402 | 220007977 | 1.9 | 62.8 | Curative (C) | 2014-09-09 | 2014-09-09 | AML 18 TRIAL | N | N | 220030495 | AML18 TRIAL |
| 220017403 | 220014377 | null | 47.8 | Disease modification (D) | 2014-01-21 | 2014-01-22 | Rituximab | N | N | 220030497 | RITUXIMAB |
| 220017404 | 220007986 | 1.68 | null | Curative (C) | 2015-09-08 | 2015-09-18 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030515 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017405 | 220007987 | 1.58 | 67.2 | Curative (C) | null | 2016-10-08 | AML18 PILOT TRIAL | 2 | N | 220030518 | PILOT TRIAL |
| 220017406 | 220007989 | 1.62 | 53.7 | Curative (C) | 2013-08-22 | 2013-08-22 | Dasatinib | N | null | 220030520 | DASATINIB |
| 220017407 | 220007991 | 1.67 | 54.6 | Curative (C) | 2013-08-12 | 2013-08-12 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030524 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017408 | 220007995 | null | 70.6 | null | null | 2014-12-25 | AML18 PILOT TRIAL | 1 | N | 220030530 | PILOT TRIAL |
| 220017409 | 220014385 | 1.6 | 63 | Curative (C) | 2017-12-10 | 2018-03-20 | AML18 PILOT TRIAL | N | N | 220030531 | PILOT TRIAL |
| 220017410 | 220007999 | 1.77 | 101.5 | Curative (C) | 2016-02-08 | 2016-03-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030535 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017411 | 220008003 | 1.94 | 84.9 | null | 2018-05-20 | 2018-05-24 | Rituximab | N | N | 220030537 | RITUXIMAB |
| 220017412 | 220008004 | 1.61 | null | Palliative (P) | 2014-10-29 | 2015-08-02 | Dasatinib | N | N | 220030541 | DASATINIB |
| 220017413 | 220008007 | 1.57 | 0 | Disease modification (D) | 2014-06-01 | 2014-06-03 | Dasatinib | 2 | N | 220030541 | DASATINIB |
| 220017414 | 220008011 | 1.69 | 73 | Disease modification (D) | 2014-07-31 | 2014-10-29 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030561 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017415 | 220008015 | 1.62 | 57.5 | Disease modification (D) | 2017-08-29 | 2017-09-04 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030565 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017416 | 220008019 | 1.58 | 89 | Curative (C) | 2015-03-01 | 2015-03-17 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030571 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017417 | 220008022 | 1.87 | null | Disease modification (D) | 2014-09-30 | 2014-10-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030584 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017419 | 220008027 | null | 0 | Palliative (P) | 2016-04-02 | 2016-04-03 | Dasatinib | N | null | 220030597 | DASATINIB |
| 220017420 | 220014396 | 1.77 | null | Palliative (P) | 2016-08-27 | 2016-08-27 | Dasatinib | 02 | N | 220030600 | DASATINIB |
| 220017421 | 220008030 | null | 97 | Disease modification (D) | 2016-04-25 | 2016-07-12 | AML18 PILOT TRIAL | Y | N | 220030624 | PILOT TRIAL |
| 220017422 | 220008034 | 1.6 | 82.2 | Palliative (P) | 2012-06-08 | 2014-12-20 | Dasatinib | 01 | N | 220030630 | DASATINIB |
| 220017423 | 220008040 | 0 | 48.6 | Adjuvant (A) | 2018-11-29 | 2018-12-02 | Dasatinib | 02 | null | 220030651 | DASATINIB |
| 220017424 | 220014402 | null | 95.2 | Curative (C) | 2018-01-03 | 2018-01-17 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030653 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017425 | 220008044 | null | 60.8 | Curative (C) | 2013-03-18 | 2013-05-01 | AML18 PILOT TRIAL | N | null | 220030661 | PILOT TRIAL |
| 220017426 | 220008047 | 1.64 | 91 | Curative (C) | 2017-04-19 | 2017-04-20 | Dasatinib | N | N | 220030664 | DASATINIB |
| 220017427 | 220008049 | null | 80.75 | Curative (C) | 2015-09-27 | 2015-12-07 | AML 18 TRIAL | Y | null | 220030685 | AML18 TRIAL |
| 220017428 | 220017861 | 1.78 | 63.4 | Palliative (P) | 2013-02-27 | 2013-04-15 | AML 18 TRIAL | N | N | 220030685 | AML18 TRIAL |
| 220017429 | 220008053 | 1.73 | 0 | Palliative (P) | 2014-03-04 | 2014-03-06 | Dasatinib | N | N | 220030693 | DASATINIB |
| 220017430 | 220008054 | 1.72 | 95.7 | Curative (C) | 2017-10-08 | 2017-10-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030694 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017431 | 220008055 | 1.9 | 79 | Curative (C) | 2017-08-07 | 2017-08-21 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030706 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017432 | 220008057 | 1.6 | 65 | Curative (C) | 2014-02-09 | 2014-02-17 | Dasatinib | N | N | 220030712 | DASATINIB |
| 220017433 | 220008059 | 1.6 | 80.5 | Curative (C) | 2017-09-19 | 2017-09-22 | AML18 PILOT TRIAL | N | N | 220030713 | PILOT TRIAL |
| 220017434 | 220008062 | 1.65 | 66.1 | Disease modification (D) | 2016-02-23 | 2016-02-25 | RUXOLITINIB | 02 | N | 220030719 | RUXOLITINIB |
| 220017435 | 220008064 | 1.56 | 0 | Disease modification (D) | 2018-01-16 | 2018-01-16 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | 220030722 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017436 | 220008065 | 1.28 | 72.5 | Curative (C) | 2017-04-25 | 2017-04-25 | FLAG | 99 | N | 220030730 | FLAG |
| 220017437 | 220008068 | null | null | Palliative (P) | 2012-12-31 | 2013-05-16 | RUXOLITINIB | N | N | 220030733 | RUXOLITINIB |